<DOC>
	<DOCNO>NCT03099408</DOCNO>
	<brief_summary>We try determine Oral Metronidazole Lactobacillus Vaginal Suppositories well Oral Metronidazole Preventing Recurrence Bacterial Vaginosis</brief_summary>
	<brief_title>Oral Metronidazole With Lactobacillus Vaginal Suppositories Prevent Recurrence Bacterial Vaginosis</brief_title>
	<detailed_description>Bacterial vaginosis ( BV ) prevalent cause symptomatic vaginal discharge U.S. associate complication include preterm delivery infant , pelvic inflammatory disease ( PID ) , urinary tract infection ( UTI ) acquisition/transmission sexually transmit disease ( STDs ) include human immunodeficiency virus ( HIV ) . Control BV advocate mean decrease prevalence complication . However , etiology BV remain unknown current treatment regimen inadequate term initial cure recurrence rate . Based currently national guideline use oral metronidazole 400 BID 7 day , high recurrence rate BV report . We hypothesize Oral Metronidazole Lactobacillus Vaginal Suppositories well Oral Metronidazole Preventing Recurrence Bacterial Vaginosis</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Women least 18 year age Have symptoms vaginal odor or/discharge Meet clinical ( Amsel ) criteria BV Willing participate research Presence another vaginal infection STD Allergy metronidazole Pregnant nursing Use oral intravaginal antibiotic within past 2 week HIV chronic disease Inability keep return appointment Contraindications Lactobacillus Vaginal Suppositories（those without sexual history）</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Recurrence</keyword>
	<keyword>Lactobacillus Vaginal Suppositories</keyword>
</DOC>